Financial Ratios

GENPHARMASEC LTD.

NSE : NABSE : 531592ISIN CODE : INE861N01036Industry : Dyes & PigmentsHouse : Private
BSE2.29-0.04 (-1.72 %)
PREV CLOSE ( ) 2.33
OPEN PRICE ( ) 2.29
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 280089
TODAY'S LOW / HIGH ( )2.29 2.29
52 WK LOW / HIGH ( ) 1.697.31
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)0.04-0.010.060.050.11
   CEPS(Rs)0.02-0.010.040.030.01
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)0.550.560.680.819.27
   Tax Rate(%)-299.4352.7416.7016.2619.68
Margin Ratios
   Core EBITDA Margin(%)1.01-1.915.603.92-23.24
   EBIT Margin(%)1.32-1.627.087.3076.65
   Pre Tax Margin(%)1.10-1.627.087.3076.65
   PAT Margin (%)4.41-0.775.906.1261.56
   Cash Profit Margin (%)4.49-0.715.966.1561.63
Performance Ratios
   ROA(%)5.53-0.854.784.352.12
   ROE(%)7.33-1.397.815.362.40
   ROCE(%)2.00-2.467.615.932.65
   Asset Turnover(x)1.251.100.810.710.03
   Sales/Fixed Asset(x)175.85267.06339.92521.3869.09
   Working Capital/Sales(x)1.511.791.091.620.05
Efficiency Ratios
   Fixed Capital/Sales(x)0.010.000.000.000.01
   Receivable days86.9593.34124.6978.1835.01
   Inventory Days139.93117.3695.4276.530.00
   Payable days59.2191.62120.3066.48
Valuation Parameters
   PER(x)76.600.00138.15278.22146.53
   PCE(x)75.23-780.09136.79276.871463.72
   Price/Book(x)5.629.9111.8516.0216.83
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)3.425.517.9916.86888.23
   EV/Core EBITDA(x)244.03-351.28111.81229.901157.82
   EV/EBIT(x)258.27-340.03112.73230.841158.82
   EV/CE(x)4.586.966.1211.2415.41
   M Cap / Sales3.375.578.1517.02902.10
Growth Ratio
   Net Sales Growth(%)-6.6128.2229.134298.73360.29
   Core EBITDA Growth(%)183.31-128.1825.75320.55346.06
   EBIT Growth(%)176.19-129.3525.23319.20347.40
   PAT Growth(%)637.15-116.6524.57337.06384.37
   EPS Growth(%)634.21-113.1124.57-56.30-92.72
Financial Stability Ratios
   Total Debt/Equity(x)0.200.000.000.000.00
   Current Ratio(x)9.173.433.742.78445.57
   Quick Ratio(x)4.481.862.672.17445.57
   Interest Cover(x)6.03
   Total Debt/Mcap(x)0.040.000.000.000.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.